---
title: "HUAPONT LIFE SCIENCES hit the limit down, reaching a new low in over 4 months, with an annual expected loss exceeding 217 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/225505151.md"
description: "HUAPONT LIFE SCIENCES hit the daily limit down, reporting a price of 3.93 yuan, creating a new low in over 4 months, with a trading volume increasing to 263 million yuan and a total market value of 7.76 billion yuan. The company announced last Friday evening that the net profit attributable to shareholders of the listed company for 2024 is expected to be a loss of 310 million to 217 million yuan, compared to a profit of 302 million yuan in the same period last year, marking a year-on-year loss. During the reporting period, the goodwill generated from the acquisition of Baisheng Pharmaceutical still showed signs of impairment. In addition, the company's agricultural chemical new materials segment is affected by industry cyclicality, with some corresponding asset groups showing signs of impairment"
datetime: "2025-01-20T05:46:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/225505151.md)
  - [en](https://longbridge.com/en/news/225505151.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/225505151.md)
generator: "portal-rs"
---

# HUAPONT LIFE SCIENCES hit the limit down, reaching a new low in over 4 months, with an annual expected loss exceeding 217 million yuan

HUAPONT LIFE SCIENCES hit the limit down, reporting a price of 3.93 yuan, creating a new low in over 4 months, with a trading volume expanding to 263 million yuan and a total market value of 7.76 billion yuan. The company announced last Friday evening that the net profit attributable to shareholders of the listed company for 2024 is expected to be a loss of 310 million to 217 million yuan, compared to a profit of 302 million yuan in the same period last year, marking a year-on-year loss. During the reporting period, the goodwill generated from the acquisition of Baisheng Pharmaceutical still showed signs of impairment. In addition, the company's agricultural chemical new materials segment is affected by industry cyclicality, with some corresponding asset groups showing signs of impairment

### Related Stocks

- [002004.CN](https://longbridge.com/en/quote/002004.CN.md)
- [300758.CN](https://longbridge.com/en/quote/300758.CN.md)
- [000952.CN](https://longbridge.com/en/quote/000952.CN.md)
- [002648.CN](https://longbridge.com/en/quote/002648.CN.md)
- [300718.CN](https://longbridge.com/en/quote/300718.CN.md)
- [601137.CN](https://longbridge.com/en/quote/601137.CN.md)
- [03368.HK](https://longbridge.com/en/quote/03368.HK.md)
- [603125.CN](https://longbridge.com/en/quote/603125.CN.md)
- [00119.HK](https://longbridge.com/en/quote/00119.HK.md)
- [600346.CN](https://longbridge.com/en/quote/600346.CN.md)

## Related News & Research

- [10:44 ETHearingLife Introduces Oticon Reveal, the World's First Dual AI-Powered Hearing Aid](https://longbridge.com/en/news/296804127.md)
- [08:03 ETShokz Introduces OpenRun Air 2 and OpenFit Air 2, Expanding Its Bone Conduction and Open-Ear True Wireless Lineups](https://longbridge.com/en/news/296784797.md)
- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [SalMar – Record-strong biological performance](https://longbridge.com/en/news/296859687.md)
- [09:02 ETIMAGE Skincare Expands Its GLP-1-Targeted Skincare Innovation with New VOL.U.LIFT™ BODY Sculpt + Firm Treatment Complex](https://longbridge.com/en/news/296792631.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**